Rekvina Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Rekvina Laboratories Ltd · Financial Result · 13 Nov 2026, 11:40 pm
Rekvina Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 356 (+1712.5% YoY | +432.0% QoQ) ■ EBITDA: 26.8 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 7.5 (Loss to Profit YoY | Loss to Profit QoQ) ■ PAT: 9.3 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 0.09 (Loss to Profit YoY | Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Rekvina Laboratories Ltd
- Reg. 32 Statement of Deviation & Variation · 13 Nov 2026
- Appointment of Ms. Bhagyshree as a company Secretary and Compliance Officer w.e.f. 16.11.2026. · 13 Nov 2026
- Outcome of Board Meeting · 13 Nov 2026
- Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Financial Result for QTR2 · 13 Nov 2026
- Intimation regarding Temporary Shutdown of Manufacturing Facility for Renovation, Upgradation and Installation of an Additional Vial Manufacturing Line. · 27 Oct 2026
- Appointment of Mr. Subrata Samanta as a Chief Financial officer of the company with effect from 07.10.2026. · 08 Oct 2026
- AGM Voting Results along-with Scrutinizer Report on E-Voting · 30 Sept 2026
- Summary of Proceeding of Annual General Meeting · 29 Sept 2026
